(NASDAQ: GNTA) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.
Genenta Science Spa's earnings in 2025 is -$9,687,494.On average, 1 Wall Street analyst forecast GNTA's earnings for 2025 to be -$19,570,157, with the lowest GNTA earnings forecast at -$19,570,157, and the highest GNTA earnings forecast at -$19,570,157. On average, 1 Wall Street analyst forecast GNTA's earnings for 2026 to be -$19,935,954, with the lowest GNTA earnings forecast at -$19,935,954, and the highest GNTA earnings forecast at -$19,935,954.
In 2027, GNTA is forecast to generate $8,413,338 in earnings, with the lowest earnings forecast at $8,413,338 and the highest earnings forecast at $8,413,338.